Are you Stephen Harnicar?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 2 invites waiting! - Read the latest clinical news, personalized to your specialty.
Education & Training
Duquesne UniversityPharmD, 2006
Publications & Presentations
PubMed
- 71 citationsEntrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of NTRK, ROS1, and ALK fusion-positive solid tumors.Dazhi Liu, Michael Offin, Stephen Harnicar, Bob T. Li, Alexander Drilon
Therapeutics and Clinical Risk Management. 2018-07-20 - 37 citationsRivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer.Eva S. Laube, Anthony F. Yu, Dipti Gupta, Yimei Miao, Patrick Samedy
The American Journal of Cardiology. 2017-07-15
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-6227
